| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Retinopathy | |||||
| Blindness | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Retinal Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Diabetes Complications | |||||
| Diabetes Mellitus | |||||
| Diabetic Angiopathies | |||||
| Endocrine System Diseases | |||||
| Eye Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Sensation Disorders | |||||
| Signs and Symptoms | |||||
| Vascular Diseases | |||||
| Vision Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Xenon Photocoagulation | |||||
| Argon Photocoagulation | |||||
| Photocoagulation | |||||
| 5 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||
|
